Ralph Schiess
Algemeen Directeur bij ONCONETIX, INC.
Vermogen: 32 370 $ op 30-04-2024
Profiel
Ralph Schiess is the founder and Chief Executive Officer of Proteomedix AG, a company founded in 2010.
He is currently the Chief Executive & Science Officer at Onconetix, Inc., a position he started in 2023.
Dr. Schiess has a graduate degree from the University of Zurich and a doctorate degree from the Swiss Federal Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ONCONETIX INC
1.21% | 05-04-2024 | 269 749 ( 1.21% ) | 32 370 $ | 30-04-2024 |
Actieve functies van Ralph Schiess
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCONETIX, INC. | Algemeen Directeur | 12-01-2024 |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Algemeen Directeur | 01-01-2010 |
Opleiding van Ralph Schiess
| University of Zurich | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
